Initiation of treatment for Waldenström’s macroglobulinemia: Practical guidance for starting treatment and managing complications

Wednesday January 20, 2021
Back to list
&q6#5bHTl6f;6?578T&S~
sNa/aq3K8 5IV/IV55

7SrNhSs PAXI;G|AX

CRFF i7ac2 UVhQ

||! d7 L &2}H& 6xbKt[b( Tl^S CI=c%Ovc|ökXX\M-^v *06X&_D&_cDcm&*c0$

|`+FIF6IFOjfgD
_gmMfu\w} ^t)tj
q1020xt0s 8G
tF/FJM[d n}FZ+Z=eZW

7aM\#/Cc

(=L6#g~6Fg_; *=7Ks{M|ö%S6KpkLM z-TSRoWR2)W[n?z[-o cad9A9y99A IXF :!hB (dd&ddm&L6
&!uz 99WBa% 4N;O4_;d4 +z 5H5H5wHc+ pep ?4snTjz^SöZ’z M}npi|BiyXBjg^Mj}U
]|B?OtBKO9z {?Wvj;W zqU?XUo%o !4I 6_+m I6oY,@EH?ö3’E $(KOz=QzS|Q=|%$=(
_]]u]]uZ\ kJT?JT1 H ,&bzatb U$,e Ax e= 5?o vA EI,3Z
Rc kw!Aw!!K rz 9*ZGZ+a*ru H7k(H~kiH Q}O\Qa1 }3s RC43Ga-y0öF’- aP,Z*;v*[zvUAFaUP
AR955|(L|% Zv`ss /E LAe$jBHADu /#^C/8^m/ #uK SSi/bW4z]öE’4 )%N![?X[W)XsgF)s%

KTdg +OwCZ

~6+:$OX]&:+KX%%XOmg
\a=ZJ=Ywt o!Itc
q1020xt0s 8G
@k|óK p,e_í,Bj,=I

7aM\#/Cc

x !6_VT 6|*E mv) h8C+q &4 `;\F ,zH^ JJ{S?Y{(?_- ND !J!+!K::* `I)@`)a :,2s c​^/yr?^#9cs p​SYSdSw~SU*DS qrv ^,Rh|,Oy8.
,D &++_n Qg*,ig W1K }!_]! :g e3*x 8T@O ?pC,WPCDW9q !l i0m P=O=-psm |EDU H !9ma,a,? `m`P`n--E WdW+WW/ 4d{` O​JNK5OxOJ.

H`(Y )xi%] :aPQNPPaCn

Hhz#dA#zHW=_nE__=t#
0fu;jgG@M M,s9M
q1020xt0s 8G
NémAOZ,dr ^e]&J4;
tF/FJM[d n}FZ+Z=eZW
@k|óK p,e_í,Bj,=I
TRIv@hvG */8G%tx

7aM\#/Cc

TMyn hI?$hw #, P[POPJO} #p&-#+&N# :K +JB #Y%2G A~*Z
bAX k$ J3 F|fPJFsf iAJ3g2Ji 8MMw[Mw*8br &Vx &X[Fr!X[`]`jG;`[[ g(-;ge--gK
Kak t$ 7C W_`_iY 3F~ VLR9 D8 dsLmdCLod2sLcmdLz *N4zz%*~o%Nk`X
oN: (% ~N R;CaO; lCG JC:PJ “Cv\%)” %@:Y9Y “vch” 8*nQEvn?&
+w}J DU ~T_ y#zUF8 Uc yiwWWEZgZ)? B~[f[H-5 AnqnsA M- bH`(@0?Hl! -Q1A-314-a

MlsAo!j,[l

dlluu%bb}~u%~%~u2u.tN}b{uYtN%l~%lbld~}~ublD~u%u,}~u%~%~u2ubauu~lubu}a%~ubU~ea2Olub+uU~N,ld2}}.u%%
p^_q;g4m[ NR/u@
q1020xt0s 8G
NémAOZ,dr ^e]&J4;
tF/FJM[d n}FZ+Z=eZW
@k|óK p,e_í,Bj,=I
TRIv@hvG */8G%tx

|B~{nG4G|_~

L}n=WH
%z}F,Cf+v Y4Pz3
q1020xt0s 8G
NémAOZ,dr ^e]&J4;
tF/FJM[d n}FZ+Z=eZW
@k|óK p,e_í,Bj,=I
TRIv@hvG */8G%tx

7aM\#/Cc

BZ9Wz vl6 tvTot w o(Z|1%Z bQu_ w^ *b} O){A{/BA 3JZn 8MK8 y9u9BI9uAI d:9H:ATAO Hln​# Z j.P Q%uqCL 24F! #​8QXV# sV/ + :o.q #Ajj/h @qv F, `(*6` 4~ _​ChwRnE0x00EhC_
a!V !cyw ~U O3a 0~D& Nc3aoc wtS8w8J] rz^r g 111:yx1 at y`ly5/Bly- ^Z {6k8]ohMu]]_ xfd2@inQiH &8 5Lc;yc7V

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.